Innospec Inc. (NASDAQ:IOSP) Stake Boosted by Blue Trust Inc.

Blue Trust Inc. increased its position in shares of Innospec Inc. (NASDAQ:IOSP) by 54.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,201 shares of the specialty chemicals company’s stock after acquiring an additional 422 shares during the period. Blue Trust Inc.’s holdings in Innospec were worth $136,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Ballentine Partners LLC increased its position in Innospec by 11.0% in the 4th quarter. Ballentine Partners LLC now owns 2,968 shares of the specialty chemicals company’s stock worth $327,000 after purchasing an additional 295 shares during the last quarter. ZWJ Investment Counsel Inc. grew its stake in shares of Innospec by 0.6% in the 4th quarter. ZWJ Investment Counsel Inc. now owns 43,426 shares of the specialty chemicals company’s stock valued at $4,779,000 after buying an additional 279 shares in the last quarter. Burney Co. bought a new position in Innospec during the fourth quarter valued at approximately $3,019,000. Claro Advisors LLC acquired a new stake in Innospec in the fourth quarter valued at approximately $220,000. Finally, Diversified Trust Co grew its position in Innospec by 9.5% in the fourth quarter. Diversified Trust Co now owns 3,543 shares of the specialty chemicals company’s stock worth $390,000 after acquiring an additional 306 shares in the last quarter. 96.64% of the stock is currently owned by hedge funds and other institutional investors.

Innospec Price Performance

Shares of NASDAQ:IOSP opened at $113.53 on Thursday. The stock has a market capitalization of $2.83 billion, a P/E ratio of 19.81 and a beta of 1.09. The business has a 50-day moving average of $113.01 and a two-hundred day moving average of $113.90. Innospec Inc. has a fifty-two week low of $103.65 and a fifty-two week high of $133.71.

Innospec (NASDAQ:IOSP) last posted its earnings results on Tuesday, November 5th. The specialty chemicals company reported $1.35 earnings per share for the quarter, hitting the consensus estimate of $1.35. Innospec had a return on equity of 13.33% and a net margin of 7.68%. The firm had revenue of $443.40 million during the quarter, compared to analyst estimates of $442.13 million. During the same period in the previous year, the company earned $1.59 EPS. The company’s revenue for the quarter was down 4.5% on a year-over-year basis. As a group, research analysts expect that Innospec Inc. will post 5.87 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, StockNews.com lowered shares of Innospec from a “strong-buy” rating to a “buy” rating in a research note on Saturday, January 11th.

Insider Transactions at Innospec

In related news, Director Milton C. Blackmore sold 1,035 shares of the business’s stock in a transaction dated Wednesday, November 13th. The stock was sold at an average price of $122.92, for a total transaction of $127,222.20. Following the completion of the transaction, the director now owns 9,028 shares of the company’s stock, valued at approximately $1,109,721.76. The trade was a 10.29 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.52% of the stock is owned by corporate insiders.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.